| Code | 5594D | ||||||||||
| MA number | 16/0211/20-S | ||||||||||
| Product Form: | cps dur 28x20 mg (blis.Al/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Zentiva, k.s., Czechia | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 28.09.2020 |
| SPC: |
SPC_Xanirva 20 mg_cps dur_03_2024.pdf
|
| PIL: |
PIL_Xanirva 15 mg_20 mg_cps dur_03_2024.pdf
|
| Dokument: |
Rivaroxabán_Príručka pre predpisujúceho lekára.pdf
|
| Safety feature | Yes |
| Data update: | 20.09.2024 |
